These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28101228)

  • 21. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma.
    Kim MN; Lee SM; Kim JS; Hwang SG
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):809-817. PubMed ID: 31385002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection.
    Ding T; Xu J; Zhang Y; Guo RP; Wu WC; Zhang SD; Qian CN; Zheng L
    Cancer; 2011 Nov; 117(21):4878-89. PubMed ID: 21480209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
    Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible correlation between iron deposition and enhanced proliferating activity in hepatitis C virus-positive hepatocellular carcinoma in Myanmar (Burma).
    Soe K; Hishikawa Y; Fukuzawa Y; Win N; Yin KS; Win KM; Myint AA; Koji T
    J Gastroenterol; 2007 Mar; 42(3):225-35. PubMed ID: 17380281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Significance of Serum Haptoglobin and Protein Disulfide-Isomerase A3 in the Screening, Diagnosis, and Staging of Colorectal Cancer.
    Niu Y; Xue J; Wu X; Qu M; Wang L; Liang W; Li T
    Front Pharmacol; 2022; 13():935500. PubMed ID: 35860021
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
    Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
    World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of vacuolar protein sorting 4B (VPS4B) is associated with accelerated cell proliferation and poor prognosis in human hepatocellular carcinoma.
    Jiang D; Hu B; Wei L; Xiong Y; Wang G; Ni T; Zong C; Ni R; Lu C
    Pathol Res Pract; 2015 Mar; 211(3):240-7. PubMed ID: 25547899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein disulfide isomerase A3 as novel biomarker for endometrial cancer.
    Yu F; Liu X; Li M; Liu X; Wang X; Guo M
    Front Oncol; 2023; 13():1247446. PubMed ID: 37909009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
    Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death.
    Saran S; Tran DD; Ewald F; Koch A; Hoffmann A; Koch M; Nashan B; Tamura T
    Oncogene; 2016 Jul; 35(29):3872-9. PubMed ID: 26549021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of TUTF1 expression on the proliferation, apoptosis and prognosis of hepatocellular carcinoma cells].
    Li ZJ; Li JS; Li DY; Pu T
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):879-884. PubMed ID: 31941243
    [No Abstract]   [Full Text] [Related]  

  • 38. Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients.
    Yang H; Xu M; Chi X; Yan Q; Wang Y; Xu W; Zhuang K; Li A; Liu S
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):554-563. PubMed ID: 28363424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.
    Huang S; Li J; Tam NL; Sun C; Hou Y; Hughes B; Wang Z; Zhou Q; He X; Wu L
    Mol Carcinog; 2019 Apr; 58(4):603-615. PubMed ID: 30556610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
    Chen ZY; Wang T; Gan X; Chen SH; He YT; Wang YQ; Zhang KH
    Oncol Lett; 2020 Jun; 19(6):3889-3898. PubMed ID: 32382336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.